To find out more about the cookies we use and how to delete them, see our privacy policy.
Fortunately, the underlying goals behind the peptide are easily addressable through other treatment options
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
doi: 10.1016/j.cvsm.2020.05.001
Leave it there overnight
Clinically proven ingredients, convenient doses, trusted global brands, and a direct route to vibrant energy, strong immunity, and total health make injectable vitamins the #1 choice for modern wellness